| Financial Year |
March 31 2023 |
| Monetary Funds |
5,385,795,427.91 |
| Held-for-trading Financial Assets |
7,568,010,000.00 |
| Notes Receivable |
188,773.24 |
| Accounts Receivable |
218,749,546.58 |
| Advances to Suppliers |
111,511,859.39 |
| Other Receivables |
76,015,760.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
971,206,814.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
256,967,176.48 |
| Total Current Assets |
14,595,760,690.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,949,061,549.20 |
| Under-construction Projects |
634,151,549.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
320,989,604.63 |
| R&D expenses |
-- |
| Goodwill |
45,133,442.04 |
| Long-Term Deferred and Prepaid Expenses |
18,232,088.71 |
| Deferred Income Tax Assets |
199,868,097.50 |
| Other Non-Current Assets |
79,251,499.55 |
| Sub-Total of Non-Current Assets |
3,264,788,503.98 |
| Total Assets |
17,860,549,194.41 |
| Short-Term Loans |
869,065,312.48 |
| Trading Financial liabilities |
18,200,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
1,566,854,315.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
187,272,368.22 |
| Taxes Payable |
324,440,676.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
570,180,053.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,320,930.11 |
| Other Current Liabilities |
112,526,467.93 |
| Sub-Total of Current Liabilities |
4,524,683,635.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,491,518.52 |
| Other Non-Current Liabilities |
35,294,148.70 |
| Sub-Total of Non-Current Liabilities |
161,661,341.54 |
| Total Liabilities |
4,686,344,977.51 |
| Paid-In Capital(Or Share Stock) |
601,077,590.00 |
| Capital Surplus |
3,886,999,891.82 |
| Surplus Reserve |
302,797,998.73 |
| LESS:Treasury Stock |
129,612,354.00 |
| Undistributed Profits |
8,492,618,793.64 |
| Minority Stockholder's Interest |
17,068,791.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,157,135,425.19 |
| Owner's Equity（Stockholder's Equity） |
13,174,204,216.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,860,549,194.41 |
